Company intelligence / Profile preview

Columbia

Vicenza, Veneto, Italy

Ownership: Public · COLM
Development stage: Other

Overview

Columbia Bio-Tech has demonstrated significant technical success in industrial-scale enzymatic hydration of acrylonitrile and other nitrile compounds, offering a greener, higher-yield alternative to classical chemical methods. Patent applications and pilot plant data support scalable, efficient, and more sustainable chemical/pharmaceutical intermediate production.

Modalities: BiocatalystMicrobial fermentationEnzyme
Industry: Non-Drug Biotech

Partnerships

Universities and research institutes in Italy

Financials

Market cap: $3B
Total revenue: $614.4M
Enterprise value: $2.8B

Beyond the preview

Go deeper on Columbia.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Columbia.

Explore the full profile